电子束辐射修饰的碳素甲基基微球基静血材料具有强烈的血细胞吸附作用,用于控制出血
Fan Leng1,2, Taotao Li2, Tongfei Li1
1Department of Pharmacology, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, China. fanleng@whu.edu.cn.
Biomaterials science
|July 17, 2023
概括
一种新型的碳甲基微球血静剂 (CCM-g-AA@DA) 有效地控制了凝血障碍中的出血. 这种先进的药物显著减少了血液流失和出血时间,提供了卓越的静血潜力.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 纳米技术在医学中的应用
背景情况:
- 有效控制凝血病出血对于减少感染和死亡率至关重要.
- 目前的微小圈血静剂在实现及时的出血控制方面面临着挑战.
研究的目的:
- 开发和评估一种新型血液静止剂,CCM-g-AA@DA,用于有效的凝血病出血管理.
- 为了研究合成的微球的静血效果和特性.
主要方法:
- 通过电子束辐射诱导的烯酸和多巴胺合的接种聚合合成碳甲基微球 (CCM).
- 显微球吸附的特征,血细胞亲和力,组织粘附,血液兼容性和生物降解性.
- 在体内评估CCM-g-AA@DA与Fe3+在老鼠抗凝血剂出血模型.
主要成果:
- 合成的CCM-g-AA@DA微球表现出红细胞的增强吸附 (约. 100倍增加) 和改善组织粘附.
- 该药物表现出良好的血液兼容性和生物降解性.
- 用Fe3+的CCM-g-AA@DA在老鼠中显著减少了~90%的出血时间和血液损失,性能优于AviteneTM.
结论:
- CCM-g-AA@DA显示显著的承诺作为一个有效的止血剂在凝血障碍管理出血.
- 这种基于微球的药物为及时控制出血提供了一种优越的替代品.
相关概念视频
Introduction to Hemostasis
8.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763


